What is CRISPR Therapeutics's change in other assets?

CRISPR Therapeutics (CRSP) reported change in other assets of $247K in Q1 2026.

How has CRISPR Therapeutics's change in other assets changed year-over-year?

CRISPR Therapeutics's change in other assets decreased by 61.0% year-over-year, from $634K to $247K.

What is the long-term trend for CRISPR Therapeutics's change in other assets?

Over 2 years (2023 to 2025), CRISPR Therapeutics's change in other assets has grown at a -62.1% compound annual growth rate (CAGR), from -$23.22M to -$3.34M.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

CRISPR Therapeutics CRSP Change in Other Assets

Change in Other Assets at other companies

CG OncologyCGON

$8.07M+1,377%

Cogent Biosciences, Inc.COGT

$1.84M+184%

Arrowhead ResearchARWR

$13.18M+2,127%

BridgeBio PharmaBBIO

$18.85M+3,770%

Krystal Biotech, Inc.KRYS

$1.7M-50.5%

Spyre Therapeutics, Inc.SYRE

$233K+150%

Other financials

Income statement

See full

Revenue$1.5M+68.6%

Operating income-$130.2M+12.2%

Net income-$122.9M+9.6%

EPS (diluted)-$1.28+19.0%

Balance sheet

See full

Cash & equivalents$423.3M+80.0%

Total debt$787.6M+259%

Total equity$1.8B-0.8%

Total assets$2.7B+25.8%

Cash flow

See full

Operating cash flow-$108.9M-102%

CapEx$504.0K+145%

Free cash flow-$109.4M-102%

Valuation

See full

Market cap$5.33B+56.4%

Enterprise value$5.69B+69.8%

P/S1,298.3×+1,208×

Profitability

See full

Operating margin-15,754.2%-17,253pp

Net margin-13,856.5%-15,058pp

FCF margin-9,777.6%-10,759pp

Returns & leverage

See full

Return on equity-31.2%+43.7pp

Debt / equity0.4×+0.3×

Current ratio18×+2.3×

Where this comes from

Reported directly by CRISPR Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CRISPR Therapeutics's change in other assets?: CRISPR Therapeutics (CRSP) reported change in other assets of $247K in Q1 2026.
How has CRISPR Therapeutics's change in other assets changed year-over-year?: CRISPR Therapeutics's change in other assets decreased by 61.0% year-over-year, from $634K to $247K.
What is the long-term trend for CRISPR Therapeutics's change in other assets?: Over 2 years (2023 to 2025), CRISPR Therapeutics's change in other assets has grown at a -62.1% compound annual growth rate (CAGR), from -$23.22M to -$3.34M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.